When did Biodesix, Inc. report Q4 2024 earnings?

Biodesix, Inc. (BDSX) reported Q4 2024 earnings on March 3, 2025 after market close.

What were Biodesix, Inc.'s Q4 2024 revenue and EPS?

Biodesix, Inc. reported revenue of $20.4M and eps of $-0.06 for Q4 2024.

Did Biodesix, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $20.3M by $109.0K. EPS beat the consensus estimate of $-0.07 by $0.01.

Where can I find Biodesix, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-030835) directly on SEC EDGAR. The filing index links above go to sec.gov.

Biodesix, Inc. BDSX Q4 2024 Annual earnings

Reported March 3, 2025 · After market close

Revenue$20.4MBeat by $109.0K

EPS-$0.06Beat by $0.01

Revenue estimate$20.3M

EPS estimate-$0.07

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$26.0M

EPS estimate-$0.86

Financials

Q4 2024

Income statement

See full

Revenue$20.4M+39.3%

Operating income-$6.6M+3.2%

Net income-$8.3M+9.7%

EPS (diluted)-$1.03-1,044%

Balance sheet

See full

Cash & equivalents$26.2M-0.1%

Total debt$62.0M+2.2%

Total equity$20.9M+356%

Total assets$97.2M-1.9%

Cash flow

See full

Operating cash flow-$4.1M+66.7%

CapEx$839.0K-71.9%

Free cash flow-$4.9M+67.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$222.56M+31.0%

Enterprise value$258.27M+26.5%

P/S3.1×-0.3×

Profitability

See full

Operating margin-48.4%-14.4pp

Net margin-60.2%-18.2pp

FCF margin-72.7%-13.1pp

Returns & leverage

See full

Return on equity-337.3%-52.8pp

Debt / equity3×-10.3×

Current ratio2.8×+1.6×

Segments

By product

See full

Diagnostic Tests$17.2M+34.4%

Development Services$3.2M—

Versus estimates

Revenue

Q1 2026$25.6MBeat by $2.4M Q4 2025$28.8MBeat by $3.0M Q3 2025$21.8MMiss by $4.5M Q2 2025$20.0MBeat by $1.6M Q1 2025$18.0MMiss by $4.6M

Q4 2024$20.4MBeat by $109.0K

Diluted EPS

Q1 2026-$0.81Beat by $0.32 Q4 2025-$0.49Beat by $0.56 Q3 2025-$1.16Beat by $0.44 Q2 2025-$1.60Miss by $0.20 Q1 2025-$0.08In line

Q4 2024-$0.06Beat by $0.01

Ask the moment Biodesix, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Biodesix, Inc. report Q4 2024 earnings?: Biodesix, Inc. (BDSX) reported Q4 2024 earnings on March 3, 2025 after market close.
What were Biodesix, Inc.'s Q4 2024 revenue and EPS?: Biodesix, Inc. reported revenue of $20.4M and eps of $-0.06 for Q4 2024.
Did Biodesix, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $20.3M by $109.0K. EPS beat the consensus estimate of $-0.07 by $0.01.
Where can I find Biodesix, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-030835) directly on SEC EDGAR. The filing index links above go to sec.gov.